Pediatric Bioavailability

Pediatric Bioavailability is the proportion of an administered drug dose that reaches the systemic circulation intact in a pediatric population, distinguishing it from adult bioavailability by accounting for age-related physiological, metabolic, and developmental factors affecting absorption, distribution, and clearance in infants, children, and adolescents.

117

Publications

4.2K

Citations

634

Authors

268

Institutions

Publications per year

2017–2026

22

Authors

634

  1. LW
    Lubbe Wiesner

    University of Cape Town, South Africa

    4 publications · 141 citations

    4

    h-index

  2. SM
    Susan M. Abdel‐Rahman

    Children's Mercy Hospital, United States

    3 publications · 69 citations

    3

    h-index

  3. TM
    Timothy M. E. Davis

    The University of Western Australia, Australia

    3 publications · 129 citations

    3

    h-index

  4. AC
    Anneke C. Hesseling

    Stellenbosch University, South Africa

    3 publications · 85 citations

    3

    h-index

  5. SK
    Sanjeev Krishna

    St George's, University of London, United Kingdom

    2 publications · 171 citations

    2

    h-index

1–5 of 634

Venues

  1. PubMed

    Repository · 12 publications · 265 citations

    10

    h-index

  2. Antimicrobial Agents and Chemotherapy

    AAC · 8 publications · 366 citations

    8

    h-index

  3. The Journal of Pediatrics

    6 publications · 188 citations

    6

    h-index

  4. International Journal of Pharmaceutics

    4 publications · 276 citations

    4

    h-index

  5. Clinical Pharmacology & Therapeutics

    CPT · 4 publications · 121 citations

    4

    h-index

1–5